Myasthenia gravis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* | *Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ | ||
** | *Thymus is abnormal in 75% of pts | ||
**Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma | |||
*No sensory, reflex, or cerebellar deficits | |||
*Respiratory failure is feared complication | |||
**Often precipitated by infection, surgery, or rapid tapering of immunosuppressive drugs | |||
==Clinical Features== | |||
#Symptoms worsen with repetitive use / as the day progresses | |||
#Muscle weakness | |||
##Proximal extremities | |||
##Neck extensors | |||
##Facial/bulbar muscles (dysphagia, dysarthria, dysphonia) | |||
#Ocular weakness | |||
##Ptosis | |||
##Diplopia | |||
##CN III, IV, or VI weakness | |||
==DDX== | ==DDX== | ||
# | #Lambert-Eaton Syndrome | ||
#Drug-induced myasthenia (penicillamine, procainamide, quines, aminoglycosides) | |||
#Botulism | |||
#Thyroid disorders | |||
# Drug- | |||
# | |||
# | |||
== | ==Management== | ||
*Always evaluate tidal volume, FEV, ability to handle secretions | |||
# | #Meds | ||
# | ##Pyridostigmine | ||
# | ###If pt's usual dose has been missed the next dose is usually doubled | ||
###PO route: 60-90mg q4hr | |||
###IV route: 1/30th of the PO dose (2-3mg) by slow IV infusion | |||
##Neostigmine | |||
###0.5mg IV | |||
#Intubation | |||
##If possible avoid depolarizing AND non-depolarizing agents | |||
###If pt requires paralysis use non-depolarizing agent at smaller dose | |||
===Testing=== | ===Testing=== | ||
Revision as of 05:29, 6 October 2011
Background
- Autoantibody degradation, dysfunction, and blockade of acetylcholine receptor at the NMJ
- Thymus is abnormal in 75% of pts
- Thymectomy resolves or improves symptoms in most pts, especially those with a thymoma
- No sensory, reflex, or cerebellar deficits
- Respiratory failure is feared complication
- Often precipitated by infection, surgery, or rapid tapering of immunosuppressive drugs
Clinical Features
- Symptoms worsen with repetitive use / as the day progresses
- Muscle weakness
- Proximal extremities
- Neck extensors
- Facial/bulbar muscles (dysphagia, dysarthria, dysphonia)
- Ocular weakness
- Ptosis
- Diplopia
- CN III, IV, or VI weakness
DDX
- Lambert-Eaton Syndrome
- Drug-induced myasthenia (penicillamine, procainamide, quines, aminoglycosides)
- Botulism
- Thyroid disorders
Management
- Always evaluate tidal volume, FEV, ability to handle secretions
- Meds
- Pyridostigmine
- If pt's usual dose has been missed the next dose is usually doubled
- PO route: 60-90mg q4hr
- IV route: 1/30th of the PO dose (2-3mg) by slow IV infusion
- Neostigmine
- 0.5mg IV
- Pyridostigmine
- Intubation
- If possible avoid depolarizing AND non-depolarizing agents
- If pt requires paralysis use non-depolarizing agent at smaller dose
- If possible avoid depolarizing AND non-depolarizing agents
Testing
- Always test FEV, consider ABG, Look for infections (resp) or meds, electrolyte problems that may have induced problem.
- Edrophonium - use caution in trying to test for crisis vs. cholinergic crisis
- Ach receptor antibodies - found 90%
- CT of thymus, TFTs, search for other immun dz
Treatment
- Plasmapherisis or plasma exchenge in acute setting
- Anticholinesterase agent such as Pyridostigmine 60 mg tid
- Corticosteroids produce good results in >80% but are reserved for those who don't respond to anti-cholinesterases and thymectomy due to adverse effects. Decreases levels of antiAch receptor Ab. Also may initially aggravate muscle weakness so usually begun in hosp & at low doses
- don't treat Myasthenic with meds that may exacerbate weakness
- search for source of infection or electrolyte problem w/ weakness
Myasthenic Crisis vs. Cholinergic
- Cholinergic - usually present w/ signs of cholinergic overactivity (miosis, sweats, salivation, GI distress-musc) & cramps, fasciculations (nicotinic)
- Myasthenic - more common, caused by noncompliance, drug interaction, infection, stress
- aminoglycosides, flouroquinolones, clinda, sulfas, erythro, ampicillin, Dilantin, phenobarb, B blockers, Ca channel Blk, procainamide, steroids, lithium, phenothiazines, MSO4, benzos, antihistamines
VERY DANGEROUS & UNRELIABLE to use Tensilon Test to distinguish between the two.
Source
Harwood Nuss p.1002
